格隆汇12月27日丨健康之路(02587.HK)公告，公司全球发售2500万股股份，每股7.80港元，所得款项净额1.09亿港元。香港公开发售股份数目占全球发售股份数目13.20%，获认购34.42倍；国际发售股份数目占全球发售股份86.80%，获认购0.98倍。假设香港公开发售于2024年12月30日(星期一)上午八时正或前在香港成为无条件，则预计股份将于2024年12月30日(星期一)上午九时正开始在联交所买卖。股份将以每手500股为买卖单位，股份代号为2587。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.